Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 Trial

被引：0

作者：

Zimmermann, Heiner ^{[1
]}

Koenecke, Christian ^{[2
]}

Dreyling, Martin H. ^{[3
]}

Pott, Christiane ^{[4
]}

Duhrsen, Ulrich ^{[5
]}

Hahn, Dennis ^{[6
]}

Meidenbauer, Norbert ^{[7
]}

Hauser, Ingeborg A. ^{[8
]}

Rummel, Mathias J. ^{[9
]}

Wolf, Dominik ^{[10
,11
]}

Heuser, Michael ^{[2
]}

Schmidt, Christian ^{[12
]}

Schlattmann, Peter ^{[13
]}

Ritgen, Matthias ^{[14
]}

Siebert, Reiner ^{[15
]}

Oschlies, Ilske ^{[16
]}

Anagnostopoulos, Ioannis ^{[17
]}

Trappe, Ralf Ulrich ^{[1
]}

机构：

[1] DIAKO Bremen, Internal Med II Hematol & Oncol, Bremen, Germany

[2] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[3] LMU Hosp, Dept Internal Med 3, Munich, Germany

[4] Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany

[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, West German Canc Ctr, Essen, Germany

[6] Katharinen Hosp Stuttgart, Dept Hematol Oncol & Palliat Care, Stuttgart, Germany

[7] Univ Erlangen Nurnberg, Dept Med, Erlangen, Germany

[8] Goethe Univ Frankfurt, Dept Nephrol, UKF, Frankfurt, Germany

[9] Justus Liebig Univ Hosp, Dept Hematol, Clin Haematol & Med Oncol, Giessen, Germany

[10] Univ Hosp Bonn, Dept Hematol Oncol & Rheumatol, Ctr Integrated Oncol Cologne Bonn, Bonn, Germany

[11] Med Univ Innsbruck, Dept Internal Med, Innsbruck, Austria

[12] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany

[13] Jena Univ Hosp, Inst Med Stat, Comp & Data Sci, Jena, Germany

[14] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[15] Ulm Univ & Ulm Univ Med Ctr, Inst Human Genet, Ulm, Germany

[16] Univ Hosp Schleswig Holstein Kiel, Hematopathol Sect, Dept Pathol, Kiel, Germany

[17] Univ Wurzburg, Inst Pathol, Wurzburg, Germany

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-146823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3555

引用

页数：6

共 38 条

[1] Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
Zimmermann, Heiner
Koenecke, Christian
Dreyling, Martin H.
Pott, Christiane
Duehrsen, Ulrich
Hahn, Dennis
Meidenbauer, Norbert
Hauser, Ingeborg A.
Rummel, Mathias J.
Wolf, Dominik
Heuser, Michael
Schmidt, Christian
Schlattmann, Peter
Ritgen, Matthias
Siebert, Reiner
Oschlies, Ilske
Anagnostopoulos, Ioannis
Trappe, Ralf U.
LEUKEMIA, 2022, 36 (10) : 2468 - 2478
[2] Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
Heiner Zimmermann
Christian Koenecke
Martin H. Dreyling
Christiane Pott
Ulrich Dührsen
Dennis Hahn
Norbert Meidenbauer
Ingeborg A. Hauser
Mathias J. Rummel
Dominik Wolf
Michael Heuser
Christian Schmidt
Peter Schlattmann
Matthias Ritgen
Reiner Siebert
Ilske Oschlies
Ioannis Anagnostopoulos
Ralf U. Trappe
Leukemia, 2022, 36 : 2468 - 2478
[3] Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Trappe, Ralf
Oertel, Stephan
Leblond, Veronique
Mollee, Peter
Sender, Monica
Reinke, Petra
Neuhaus, Ruth
Lehmkuhl, Hans
Horst, Heinz August
Salles, Gilles
Morschhauser, Franck
Jaccard, Arnaud
Lamy, Thierry
Leithaeuser, Malte
Zimmermann, Heiner
Anagnostopoulos, Ioannis
Raphael, Martine
Riess, Hanno
Choquet, Sylvain
LANCET ONCOLOGY, 2012, 13 (02): : 196 - 206
[4] Treatment stratification in B-cell PTLD after solid organ transplantation (SOT) by international prognostic index (IPI) and response to rituximab: Interim results from the PTLD-2 trial.
Trappe, Ralf Ulrich
Koenecke, Christian
Dreyling, Martin H.
Pott, Christiane
Duehrsen, Ulrich
Meidenbauer, Norbert
Hahn, Dennis
Heuser, Michael
Schmidt, Christian
Ritgen, Matthias
Siebert, Reiner
Oschlies, Ilske
Anagnostopoulos, Ioannis
Zimmermann, Heiner
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] Clinicopathologic Features of Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Following Hematopoietic Stem Cell Transplant (HSCT) Are Different from PTLD in Solid organ Recipients (SOT)
Zhou, J.
Van Besien, K.
Orazi, A.
Cesarman, E.
Knowles, D. M.
Geyer, J. T.
LABORATORY INVESTIGATION, 2014, 94 : 390A - 390A
[6] Clinicopathologic Features of Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Following Hematopoietic Stem Cell Transplant (HSCT) Are Different from PTLD in Solid organ Recipients (SOT)
Zhou, J.
Van Besien, K.
Orazi, A.
Cesarman, E.
Knowles, D. M.
Geyer, J. T.
MODERN PATHOLOGY, 2014, 27 : 390A - 390A
[7] Interim analysis of the largest prospective trial to date in adult CD20-positive post-transplant lymphoproliferative disorder (PTLD): Introducing risk-stratified sequential treatment (RSST).
Trappe, Ralf Ulrich
Dierickx, Daan
Reinke, Petra
Neuhaus, Ruth
Morschhauser, Franck
Zaucha, Jan M.
Mollee, Peter
Zimmermann, Heiner
Dreyling, Martin H.
Duehrsen, Ulrich
Verhoef, Gregor E. G.
Lehmkuhl, Hans
Subklewe, Marion
Huettmann, Andreas
Tousseyn, Thomas
Tarella, Corrado
Leblond, Veronique
Anagnostopoulos, Ioannis
Riess, Hanno
Choquet, Sylvain
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[8] Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial
Trappe, Ralf
Oertel, Stephan H. K.
Leblond, Veronique
Mollee, Peter
Sender, Monica
Reinke, Petra
Neuhaus, Ruth
Lehmkuhl, Hans
Horst, Heinz A.
Salles, Gilles Andre
Morschhauser, Franck
Jaccard, Arnaud
Lamy, Thierry
Leithaeuser, Malte
Anagnostopoulos, Ioannis
Raphael, Martine
Riess, Hanno
Choquet, Sylvain
BLOOD, 2011, 118 (21) : 401 - 402
[9] Post-transplant lymphoproliferative disorder (PTLD) after solid organ transplant (SOT): A multicenter real world analysis (RWA) of 877 patients (pts) treated in the modern era.
Jagadeesh, Deepa
Tsai, Donald Edward
Wei, Wei
Bustamante, Jean Alvarez
Wagner-Johnston, Nina D.
Berg, Stephanie
Kim, Seo-Hyun
Reddy, Nishitha M.
Sriram, Deepika
Portell, Craig
Ghione, Paola
Voorhees, Timothy
Kamdar, Manali K.
Koff, Jean Louise
Dharnidharka, Vikas
Evens, Andrew M.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[10] Risk Factors for Post-Transplant Lymphoproliferative Disorder (PTLD) and Its Impact on Patient Survival in Solid Organ Transplantation in the United States
Cho, Y. W.
Sampaio, M. S.
Hutchinson, I. V.
Qazi, Y.
Shah, T.
Fong, T. -L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 510 - 511

← 1 2 3 4 →